We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
A cluster randomised trial in Pakistan
The study found that community health volunteers provided a critical link to Syrian refugees with noncommunicable diseases
Information explaining diabetic retinopathy, a disease screened for by the NHS diabetic eye screening (DES) programme.
This trial was conducted during routine outpatient department hours in a primary health care setting in Puducherry, India
A tool that provides hospital admissions information for children with asthma, diabetes or epilepsy.
Further information on what drivers with different types of diabetes need to tell DVLA by law.
The DOVE tool shows the relationship between spending on diabetes care and clinical outcomes in GP and clinical commissioning group (CCG) areas.
An evaluation questionnaire was based on the measures in the WHO policy on TB infection control in healthcare facilities
Information and guidance on a range of medical devices for users and patients.
How to use a budget impact analysis to evaluate your digital health product.
Synthesises lessons and successful approaches from research in Pakistan, China, Bangladesh, Nigeria and Swaziland
Overview of the UK's diabetes research infrastructure and advantages of investment in the UK's life science sector to support new treatments.
This study reported high prevalence, especially of undiagnosed cases amongst adults, most have uncontrolled blood sugar levels
How investigators and sponsors should manage clinical trials during COVID-19
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).